Genetic Variation and Variability in Posaconazole Pharmacokinetics in Children
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 04 Aug 2017
At a glance
- Drugs Posaconazole (Primary)
- Indications Acute myeloid leukaemia; Aplastic anaemia; Myelodysplastic syndromes; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Pharmacokinetics
- 31 Jul 2017 Planned End Date changed from 1 Jul 2016 to 1 Dec 2017.
- 31 Jul 2017 Planned primary completion date changed from 1 Jul 2016 to 1 Dec 2017.
- 31 Jul 2017 Status changed from recruiting to active, no longer recruiting.